CHARLESTON â The fourth week of Huntington and Cabell Countyâs opioid trial against three drug distributors was highlighted by an email showing McKesson Corp. employees cheering Appalachian trends shifting away from pills to illicit drugs in 2012.
The email was shared among McKesson employees, first by Tracey Jonas, director of regulatory processes, who shared a February 2012 article which said the DEA was seeing a sharp drop in Florida oxycodone.
Dave Gustin, a director of regulatory affairs, said pill users in Ohio and Kentucky were shifting to illicit drug use, such as heroin and meth. Jonas responded âGood . let them move to heroin and meth .we donât have to monitor that.â
CHARLESTON â The fourth week of Huntington and Cabell Countyâs opioid trial against three drug distributors was highlighted by an email showing McKesson Corp. employees cheering Appalachian trends shifting away from pills to illicit drugs in 2012.
The email was shared among McKesson employees, first by Tracey Jonas, director of regulatory processes, who shared a February 2012 article which said the DEA was seeing a sharp drop in Florida oxycodone.
Dave Gustin, a director of regulatory affairs, said pill users in Ohio and Kentucky were shifting to illicit drug use, such as heroin and meth. Jonas responded âGood . let them move to heroin and meth .we donât have to monitor that.â
Cabell County Sheriff Chuck Zerkle
CHARLESTON – At the landmark federal opioid trial, Cabell County Sherriff Chuck Zerkle testified being directly involved in Huntington, once deemed “epicenter of the opioid crisis,” has evolved.
During his testimony May 27, Zerkle said he wanted to make a difference and to help combat issues he believes are harming the community.
“One of the reasons I ran for sheriff was I felt I could make a difference in our community,” said Zerkle, who has been a Cabell County resident since 1985 working various positions in law enforcement and private industry. Farrell
Cabell County and the City of Huntington sued the three largest pharmaceutical distribution companies – AmerisourceBergen, Cardinal Health and McKesson Corp. – in 2017 claiming the companies were largely responsible for the opioid crisis after the companies shipped more than 81 million hydrocodone and oxycodone pills to the county of just
CHARLESTON – As the landmark federal opioid trial concluded its fourth week, attorneys for Cardinal Health probed an addiction science professor from Marshall University about recovery programs and estimated costs.
The City of Huntington and the Cabell County Commission sued three of the nation’s top pharmaceutical distribution companies – AmerisourceBergen, Cardinal Health and McKesson – in 2017 seeking compensation over claims the companies helped fuel the opioid epidemic by sending more than 81 million controlled substances to the county between 2006 and 2014.
Before the start of testimony May 28, U.S. District Judge David Faber, who is overseeing the bench trial, brought up previously admitted documents that were not presented to the media. Faber said that while he does worry about how the media can misconstrue the documents, with a previous ruling in mind, he felt the public had the right to see the documents.
An email released Friday in the federal trial pitting Huntington and Cabell County against three drug distributors showed McKesson Corp. employees cheering trends that showed Appalachians were shifting away from